Dr. Opeyemi Kolawole publishes an Ideas in ALL Blog: Proposed European Union Reforms to the Supplementary Protection Certificate Framework: Implications for Access to Medicines in the EU?

by | Jul 23, 2025 | News

On 4 July 2025, the Ideas in ALL Blog published a blog post by Dr Opeyemi Kolawole, a postdoctoral researcher on the PatentsinHumans Project. The blog post examined the proposed amendments to the European Union’s Supplementary Protection Certificate (SPC) framework, including reforms which would impact SPCs for pharmaceuticals and other medicinal products. Specifically, the blog post examined whether, and to what extent, these reforms could affect access to medical products and technologies within the EU.

The Ideas in ALL Blog piece is available here!

Thank you to the ALL Institute (which co-hosts the PatentsInHumans project with the School of Law and Criminology at Maynooth University) for including the article on the Ideas in ALL Blog and to the ALL Blog Editors for their help and advice

This research was conducted as part of the PatentsInHumans project. You can find out more about the PatentsInHumans project by visiting the project website: www.patentsinhumans.eu or by watching this short video.

Recent Posts

PatentsinHumans marks Year 3! A summary of Blog Articles from 2025!

Nov 14, 2025

The PatentsInHumans project marked three years in existence on the 1st of November 2025! To mark the occasion, the project is launching a series of news items over the weeks of November about selected project publications to date. Last week, we launched two...

PatentsInHumans Team Member, Lauren Kane, publishes a blog article in Ideas in ALL: High Priced Medicines, Intellectual Property Rights, and Access Barriers: Médicins Sans Frontières Report Calls for Better Access to Tuberculosis Medicines in Europe

Oct 22, 2025

Lauren Kane recently published a short piece on the Ideas in ALL blog, entitled: “High Priced Medicines, Intellectual Property Rights, and Access Barriers: Médicins Sans Frontières Report Calls for Better Access to Tuberculosis Medicines in Europe” (17 October 2025)....